Corinne Marie Reilly, PA

Corinne Reilly practices at Hudson Dermatology in Fishkill, New York.

Corinne Reilly's NPI, 1043647415, was assigned on October 1, 2013. Corinne Reilly holds New York license 016703-1.

Corinne Reilly's primary practice is Hudson Dermatology, at 969 Main St, Fishkill, NY 12524 in Dutchess County. The practice phone is (845) 896-7730.

Corinne Reilly's primary practice is Hudson Dermatology in Fishkill, New York. The medical group on file is Hudson Dermatology. Dmand AI also links Corinne Reilly to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Corinne Reilly practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Corinne Reilly's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Corinne Reilly is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Corinne Reilly is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, head wound, hives and itchy rashes among the conditions Corinne Reilly treats.

CMS data shows 1,710 Medicare services from Corinne Reilly across 13 procedure codes in 2024, for 473 Medicare patients. Medicare paid $72,271 for them. Every service was in an office.

CMS counts 473 Medicare patients who saw Corinne Reilly in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Corinne Reilly's median patient age at 46, with 75% women.

In 2024, Corinne Reilly wrote 840 Medicare Part D claims for 326 patients. 85% of them were for generic drugs. CMS names the drug for 655 of them, across 19 drugs with 11 or more claims each, at $185,012 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Corinne Reilly for performance year 2024, reported as part of a group. Corinne Reilly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 132 general payments to Corinne Reilly from 17 drug and device companies in 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $463.